Arch Chemicals (ARJ) Swings to Q4 Loss; Guides Q1, FY09
Arch Chemicals, Inc. (NYSE: ARJ) reports Q4 loss of $0.75, versus the analyst estimate of ($0.01). Revenue for the quarter was $307.5 million, versus the consensus of $352.55 million.
Sees Q1 loss of $0.05-$0.15, versus the Street estimate of a gain of $0.15. .Sees FY09 sales up 2-4% and adj-EPS of $1.85-$2.05, versus the consensus of $2.07.
Related Categories
EarningsGuidance
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
